5/5, 8:12 AM (Source: TeleTrader)
more TeleTrader news

Vector inspects effects of EpiVacCorona 3rd dose

The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) and the State Research Center of Virology and Biotechnology VECTOR announced on Wednesday they are starting clinical trials of the effects of the possible third dose of the latter's vaccine against COVID-19, EpiVacCorona.

One of the institute's leading scientists, Alexander Ryzhikov, stated the same research done in ferrets and guinea pigs, noted the third shot led to an increase in immunity and its duration.

More recently, VECTOR stated its vaccine is effective against the British and South African variants of coronavirus. Earlier, the institute said the jab provides one-year immunity.

Breaking the News / JR